Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
national blog main
3
×
clinical trials
life sciences
amgen
andrew berens
angel investors
arboretum ventures
avapritinib
biotech
blueprint medicines
boston
boston blog main
calcitonin gene-related peptide
cancer
chronic migraine
cultivation capital
deciphera pharmaceuticals
detroit
detroit blog main
detroit top stories
drugs
eli lilly
entrepreneurship
episodic migraine
fda
fifth eye
funding
gastrointestinal stromal tumor
gist
gleevec
healthtech
heart monitor
hemodynamic instability
imatinib
indiana
indiana blog main
indiana top stories
innovation
invest michigan
jen baird
What
announced
3
×
approval
3
×
fda
developed
drug
new
seek
ann
approved
arbor
based
blueprint
cancer
capital
chasing
class
deadly
deciphera
decision
eli
eye
fifth
filing
forms
gi
headache
late
lilly
marks
medical
medicine
medicines
michigan
migraine
morning
pain
pharamceuticals
plans
prepares
prevent
Language
unset
Current search:
approval
×
announced
×
" national blog main "
×
@xconomy.com
4 years ago
Chasing Blueprint, Deciphera Plans FDA Filing for GI Cancer Drug
@xconomy.com
5 years ago
After Scoring New Capital, Fifth Eye Prepares to Seek FDA Approval
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
